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Abstract
In neurons, axons possess a molecularly defined and highly organised proximal region – the axon initial segment (AIS) – that is a
key regulator of both electrical excitability and cellular polarity. Despite existing as a large, dense structure with specialised
cytoskeletal architecture, the AIS is surprisingly plastic, with sustained alterations in neuronal activity bringing about significant
alterations to its position, length or molecular composition. However, although the upstream activity-dependent signalling path-
ways that lead to such plasticity have begun to be elucidated, the downstream mechanisms that produce structural changes at
the AIS are completely unknown. Here, we use dissociated cultures of rat hippocampus to show that two forms of AIS plasticity
in dentate granule cells – long-term relocation, and more rapid shortening – are completely blocked by treatment with blebbistatin,
a potent and selective myosin II ATPase inhibitor. These data establish a link between myosin II and AIS function, and suggest
that myosin II’s primary role at the structure may be to effect activity-dependent morphological alterations.
Introduction
Two deﬁning features of neurons – their ability to ﬁre action poten-
tials, and their maintenance of strictly deﬁned cellular polarity –
both crucially depend on a molecularly and structurally specialised
region of the proximal axon known as the axon initial segment
(AIS; Rasband, 2010; Bender & Trussell, 2012). This structure con-
tains a tightly organised and highly regulated arrangement of,
amongst others, cytoskeletal components, scaffolding molecules, cell
adhesion factors and ion channels, yet is also capable of striking
structural plasticity (Grubb & Burrone, 2010a; Grubb et al., 2011).
In response to prolonged alterations in levels or patterns of neuronal
activity, the AIS can change its location, length and/or its molecular
composition, and these changes have been associated with signiﬁ-
cant alterations in neuronal excitability (Grubb & Burrone, 2010b;
Kuba et al., 2010, 2014, 2015; Evans et al., 2013, 2015; Gutzmann
et al., 2014; Muir & Kittler, 2014; Chand et al., 2015; Horschitz
et al., 2015; Wefelmeyer et al., 2015; Dumitrescu et al., 2016).
Structural change at the AIS may therefore be part of a repertoire of
plastic mechanisms by which neurons can alter their function in
response to perturbations in their ongoing electrical activity.
However, although the AIS is known to be structurally plastic in
multiple ways, the cellular mechanisms responsible for these activ-
ity-dependent structural changes are almost entirely unknown. Some
headway has been made in elucidating the upstream signalling path-
ways necessary for AIS plasticity. In all cell types tested, this is
dependent upon calcium entry through L-type CaV1 voltage-gated
calcium channels, and in hippocampal dentate granule cells both
long-term (48 h) AIS relocation and more rapid (3 h) AIS shorten-
ing are mediated by the activity of the calcium-dependent phos-
phatase calcineurin (Evans et al., 2013, 2015; Chand et al., 2015).
But which cellular events downstream of calcineurin activity are
necessary to produce structural changes at the AIS? Here, cytoskele-
tal components of the AIS are prime suspects. Microtubule- and
actin-based dynamics are key players driving diverse forms of mor-
phological change in neurons, and the AIS is known to possess
uniquely organised structures of both microtubules and actin ﬁla-
ments (Palay et al., 1968; Watanabe et al., 2012; Xu et al., 2013;
Jones et al., 2014; D’Este et al., 2015; Ganguly et al., 2015; Leter-
rier et al., 2015). Indeed, these cytoskeletal specialisations have long
been proposed to play a role in altering AIS structure (Palay et al.,
1968), and recent data show that altering microtubule stability can
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affect AIS location in hippocampal neurons (Hatch et al., 2017).
Axons are also rich in actin-associated myosin motor proteins, with
non-muscle myosin II playing crucial roles in growth cone motility,
and myosin Va and myosin VI controlling the AIS-based ﬁltering of
dendritically- or axonally targeted proteins respectively (Arnold &
Gallo, 2014). To date, though, myosins have not been implicated in
the development, maintentance or plasticity of AIS structure per se.
Here, we demonstrate just such a role, using pharmacological
manipulations in dissociated hippocampal cultures to show that the




Humane killing for tissue collection conformed to local King’s
College London ethical approval under the UK Supplementary
Code of Practice, The Humane Killing of Animals under Schedule
1 to the Animals (Scientiﬁc Procedures) Act 1986. Hippocampi
were rapidly dissected from embryonic day (E18) Wistar rat
embryos (Charles River) of either sex in ice-cold Hank’s balanced
salt solution (HBSS). Tissue was trypsin digested (Worthington,
0.5 mg/mL; 15 min at 37 °C), then triturated by repeatedly pipet-
ting the cells using ﬁre-polished Pasteur pipettes, and ﬁnally plated
on 13 mm coverslips (45 000 cells/coverslip; VWR) coated with
poly-l-lysine (50 lg/mL; Sigma) and laminin (40 lg/mL). Cells
were incubated at 37 °C with 5% CO2 in Neurobasal medium con-
taining 1% B27, 1% foetal calf serum and 500 lM Glutamax. At
4 days in vitro (DIV), half the media was changed with Neu-
robasal plus 2% B27 and 500 lM Glutamax. At 7, DIV media was
topped up to 1 mL with fresh Neurobasal plus 2% B27 and
500 lM Glutamax. All experiments were carried out between 10–
12 DIV. Unless otherwise stated, all cell culture reagents were
obtained from Invitrogen.
Transfections
EGFP–C1 nuclear factor of activated T-cells 3 (NFAT3; referred to
as NFAT–GFP) was obtained from Addgene (plasmid 10961; depos-
ited by Toren Finkel, National Heart, Lung and Blood Institute,
Bethesda, MD, USA; Ichida & Finkel, 2001). Neuronal cultures
were sparsely transfected with NFAT–GFP at 7 DIV using Lipofec-
tamine 2000 (Invitrogen; 0.5 lg DNA and 0.5 lL lipofectamine per
well, in 1 mL media; 10 min at 37 °C).
Neuronal treatments
All treatments were performed at 10 DIV. Pharmacological agents,
()-blebbistatin (ab120425; Abcam) and dynasore (ab120192:
Abcam), were made up in DMSO at 1000-fold stock concentrations.
They were subsequently added to culture media at previously
described effective working concentrations (Newton et al., 2006;
Kollins et al., 2009) at least 30 min before control or depolarising
treatment. Long-term treatment of hippocampal cultures with
≥50 lM blebbistatin has not been reported to produce adverse effects
on neuronal health (Kollins et al., 2009). We also saw no adverse
effects of the treatment in our neurons or on their AISs, despite AIS
integrity being a sensitive readout of neuronal injury (Schafer et al.,
2009). Cultures were depolarised by adding +10 mM or +15 mM
KCl from 1M stock, or treated with +10 mM or +15 mM NaCl as
osmolarity controls.
Immunocytochemistry
Cultures were ﬁxed in 4 % paraformaldehyde (TAAB Laboratories; in
3 % sucrose, 60 mM PIPES, 25 mM HEPES, 5 mM EGTA, and 1 mM
MgCl2) for 20 min at room temperature. Cells were permeabilised for
5 min with 0.25 % Triton X-100 (Sigma) before blocking for 1 h in
10 % goat serum (GS; Sigma). Coverslips were then placed in pri-
mary antibody solution, in PBS plus 2 % GS, at relevant concentra-
tions: mouse monoclonal anti-ankyrin-G (Neuromab clone N106/36;
1 : 500) and rabbit polyclonal anti-prox1 (Sigma P1724; 1 : 1000) for
90 min. After washing in PBS, coverslips were placed in relevant sec-
ondary antibody solution (Invitrogen Alexa Fluor-conjugated antibod-
ies in 2% GS; 1 : 1000) for an additional hour, before further washing
and mounting in MOWIOL (Calbiochem). A subset of these cover-
slips was additionally stained for myosin IIb by dissolving the mount-
ing medium in PBS for ≥36 h, washing thoroughly, then repeating the
above post-ﬁxation procedure including a 3 h incubation in rabbit
polyclonal anti-myosin IIb (Covance PRB-445P; 1 : 500).
Imaging and image analysis
All imaging and subsequent analyses were performed blind to exper-
imental group. For AIS imaging and quantiﬁcation, prox1-positive
dentate granule cells (DGCs) with ankyrin-G-positive AISs of obvi-
ous somatic origin were visualised under epiﬂuorescence and
imaged using a laser-scanning confocal microscope (Carl Zeiss LSM
710). Neurons were imaged with appropriate excitation and emission
ﬁlters, with the pinhole set to 1 AU and using a 409 oil-immersion
objective (Carl Zeiss). Laser power and gain settings were adjusted
to prevent signal saturation. Images were taken with 39 or 59
zoom, 512 9 512 pixels (0.138 lm or 0.083 lm/pixel, respec-
tively), and in z-stacks with 0.5 lm steps.
Stacks were ﬂattened into single maximum intensity projections and
imported into MATLAB (MathWorks) for analysis using custom-
written functions (Evans et al., 2015; freely available at
www.mathworks.com/matlabcentral/fileexchange/28181-ais-quantification).
We identiﬁed the start of the axon using background ﬂuorescence in
the ankyrin-G channel, determining the point at which the somatic
contour began to deviate into the axonal process. We then drew a
line proﬁle starting at this point that extended down the axon,
through and past the AIS. At each pixel along this proﬁle, ﬂuores-
cence intensity values were averaged over a 3 9 3 pixel square cen-
tred on the pixel of interest. Averaged proﬁles were then smoothed
using a 40-point ( 5 lm) sliding mean and normalised between 1
(maximum smoothed ﬂuorescence, location of the AIS max posi-
tion) and 0 (minimum smoothed ﬂuorescence). AIS start and end
positions were obtained at the proximal and distal axonal positions,
respectively, at which the normalised and smoothed proﬁle declined
to 0.33. Varying this threshold between 0.1 and 0.5 produced identi-
cal results in terms of signiﬁcance for all statistical tests performed
on blebbistatin experiments.
For 48 h-treated cells, an AIS movement index (AMI; Evans et al.,
2013) was calculated for each neuron subjected to both drug and depo-
larisation using its own AIS max position (a) and the mean AIS max
position for other treatment groups [drug + 10 mM NaCl (b); solvent




A mean AMI of 1 describes an experiment in which AISs moved
as far in drug as in control, whereas an AMI of 0 indicates that AIS
relocation has been totally blocked.
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The distribution of NFAT–GFP (Evans et al., 2013) was assessed
in prox1-positive neurons by tracing separate nuclear and cytoplas-
mic regions within a single-plane confocal image (ImageJ, NIH),
and measuring the mean grey value for both nuclear and cytoplas-
mic NFAT–GFP. Then,
NFAT GFP distribution ¼ ðnucleus cytoplasmÞðnucleusþ cytoplasmÞ
Statistics
Data were analysed with Prism software (GraphPad Software). Data-
sets were assessed for Normality using a D’Agostino and Pearson
omnibus test, and were analysed using parametric or nonparametric
tests accordingly. All tests were two-tailed, with a = 0.05.
Results
We tested the involvement of myosin II in structural AIS plasticity
using the potent and selective non-muscle myosin II ATPase inhibi-
tor blebbistatin (50 lM; Straight et al., 2003; Limouze et al., 2004;
Kollins et al., 2009) during neuronal depolarisation in dissociated
cultures of rat hippocampus. We ﬁrst investigated the slow distal
relocation of the AIS produced by +10 mM KCl depolarisation over
48 h (Grubb & Burrone, 2010b; Evans et al., 2013; Muir & Kittler,
2014; Horschitz et al., 2015), focusing on dentate granule cells
(DGCs) revealed by immunocytochemical label for the transcription
factor prox1 (Williams et al., 2011; Evans et al., 2013; Lee et al.,
2013). AIS position was quantiﬁed based on immunolabel for the
scaffolding molecule ankyrin-G (AnkG). In the presence of the
DMSO solvent control, 48 h depolarisation produced the expected
~ 9 lm distal relocation of the entire AIS structure, with the start,
max and end AIS positions all shifting signiﬁcantly down the axon
away from the soma (Fig. 1A; Start position mean  SEM:
+10 mM NaCl 1.73 0.50 lm, +10 mM KCl 10.06  0.96 lm,
Tukey post-test after two-way ANOVA on ranks, P < 0.0001; Max
position: NaCl 9.97  0.86 lm, KCl 19.12  1.17 lm;
P < 0.0001; End position: NaCl 22.40  0.81 lm, KCl
31.48  1.36 lm, P < 0.0001). In the presence of 50 lM blebbis-
tatin, however, this activity-dependent relocation of the AIS was
blocked completely. AIS start, max and end positions were no
Fig 1. Myosin II is necessary for AIS plasticity. (A) Myosin II is necessary for 48 h AIS relocation. Example maximum intensity projection images (left) of
dentate granule cells labelled for ankyrin-G (AnkG) and prox1 (Px1) following 48 h NaCl or KCl treatment in the presence of DMSO or 50 lM blebbistatin.
Plot (right) shows mean  SEM of AIS start (S), max (M) and end (E) position for each treatment group. AMI, AIS movement index (see Methods). (B) Myo-
sin II is necessary for 3 h AIS shortening. Example maximum intensity projection images (left) of dentate granule cells labelled for ankyrin-G (AnkG) and
prox1 (Px1) following 3 hr NaCl or KCl treatment in the presence of DMSO or 50 lM blebbistatin. AISL, AIS length. Plot (right) shows cumulative fraction
and (inset) mean  SEM of AIS length. Two-way ANOVA with Tukey’s multiple comparison test; **, P = 0.0054; ns, non-signiﬁcant. For example images in
(A) and (B), Yellow lines, axon start; white arrowheads, AIS start and end positions; scale bar, 10 lm.
© 2017 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
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different from those under non-depolarised conditions (Fig. 1A;
Start position mean  SEM: +10 mM NaCl 2.36 0.49 lm,
+10 mM KCl 2.09  0.45 lm, Tukey post-test after two-way ANOVA
on ranks, P = 0.99; Max position: NaCl 10.00  0.68 lm, KCl
9.62  0.70 lm; P > 0.99; End position: NaCl 22.24  0.78 lm,
KCl 23.79  0.74 lm, P = 0.58), producing an AIS movement
index (AMI; see Methods) that was not signiﬁcantly different from
zero (mean  SEM -0.041  0.076; 1-sample t-test vs. 1,
P < 0.0001; vs. 0, P = 0.59).
Myosin II is therefore necessary for slow activity-dependent AIS
relocation over several days. But structural plasticity at the AIS can
also occur much more rapidly, with just 3 h depolarisation capable
of producing a signiﬁcant decrease in the structure’s length (Evans
et al., 2015). We asked whether myosin II is also necessary for such
rapid AIS shortening, by treating our neurons with 50 lM blebbis-
tatin during 3 h depolarisation with +15 mM KCl. As expected, we
found a signiﬁcant decrease in AIS length after 3 h KCl treatment
in DMSO (Fig. 1B; mean  SEM, +15 mM NaCl 19.80 
0.59 lm, +15 mM KCl 16.47  0.96 lm; Tukey post-test after 2-
way ANOVA, P = 0.0054). This activity-dependent AIS shortening
was entirely blocked, however, in the presence of 50 lM blebbistatin
(Fig. 1B; mean  SEM, +15 mM NaCl 19.46  0.57 lm, +15 mM
KCl 20.29  0.62 lm; Tukey post-test after two-way ANOVA,
P = 0.84).
To assess the potential for myosin II to locally inﬂuence structural
plasticity at the AIS, we employed immunocytochemical label for
nonmuscle myosin heavy chain IIb in conjunction with AnkG and
prox1 staining. We observed characteristic punctate label for myosin
IIb that was broadly distributed throughout each neuron (Ryu et al.,
2006), with no indication of any speciﬁc localisation or concentra-
tion at the AIS (Fig. 2). Nevertheless, myosin II immunoreactivity
was clearly present at the AIS. We observed myosin IIb puncta co-
localised with AnkG label at DGC AISs in all of our depolarisation
and drug treatment groups (Fig. 2).
In hippocampal DGCs, both slower AIS relocation and rapid AIS
shortening are known to depend on signalling through L-type CaV1
voltage-gated calcium channels and the calcium-dependent phos-
phatase calcineurin (Evans et al., 2013, 2015). Could blebbistatin be
preventing AIS plasticity by somehow inhibiting these upstream sig-
nalling events? We tested this possibility by transfecting our cells
with the calcineurin-dependent probe NFAT-GFP, which is localised
to the cytoplasm under baseline conditions but is rapidly translo-
cated to the nucleus upon calcineurin activation (Graef et al., 1999).
Indeed, here 3 h depolarisation with +15 mM KCl in DMSO pro-
duced clear nuclear translocation of the NFAT-GFP probe (Fig. 3;
NFAT distribution mean  SEM, +15 mM NaCl 0.49  0.02,
+15 mM KCl 0.64  0.02; Tukey post-test after two-way ANOVA,
P < 0.0001). This nuclear translocation was also clearly observed in
the presence of 50 lM blebbistatin, albeit to a slightly reduced
extent (Fig. 3; mean  SEM, +15 mM NaCl 0.42  0.03,
+15 mM KCl 0.41  0.03; Tukey post-test after two-way ANOVA,
P < 0.0001; Tukey post-test for DMSO vs. blebbistatin in KCl,
P < 0.0001). The involvement of myosin II in structural AIS plastic-
ity is therefore unlikely to be upstream of calcium-dependent cal-
cineurin signalling.
One cellular process known to depend on both calcineurin and
myosin II in neurons is bulk endocytosis (Evans & Cousin, 2007;
Flores et al., 2014). Could this en masse removal of cell membrane
be a crucial mechanism in mediating AIS plasticity? We tested this
hypothesis by blocking another key component in the bulk endocy-
tosis process – dynamin (Clayton et al., 2009; Nguyen et al., 2012;
Gormal et al., 2015) – using the dynamin inhibitor dynasore
(80 lM; Macia et al., 2006; Newton et al., 2006). However,
although dynasore had a depolarisation-independent effect on AIS
Fig 2. Myosin II immunoreactivity is present, but is not concentrated at the AIS. Example maximum intensity projection images of dentate granule cells
labelled for ankyrin-G (AnkG), prox1 (Px1) and myosin IIb following 3 hr NaCl or KCl treatment in the presence of DMSO or 50 lM blebbistatin. Panels on
the right show magniﬁed, split-channel images of the AIS from a neuron shown in the left panel. Yellow lines, axon start; white arrowheads, myosin IIb puncta
colocalised with ankyrin-G; AISL, AIS length; scale bars, 10 lm.
© 2017 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
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length, producing a ~2.5 lm decrease after both 3 h +15 mM NaCl
and KCl treatments (Fig. 4; DMSO mean  SEM, +15 mM
NaCl 20.65  0.76 lm, KCl 14.90  0.56 lm; dynasore, NaCl
18.17  0.62 lm, KCl 12.09  0.66 lm; effect of drug in two-way
ANOVA, F1,135 = 16.44, P < 0.0001), it had no inﬂuence whatsoever
on activity-dependent rapid AIS shortening (Fig. 4; effect of
drug x treatment interaction in 2-way ANOVA, F1,135 = 0.06,
P = 0.80; NaCl vs. KCl in DMSO, and NaCl vs. KCl in dynasore,
Tukey post-test after 2-way ANOVA, both P < 0.0001).
Discussion
We show here that structural plasticity at the AIS is blocked by
treatment with blebbistatin, a selective myosin II ATPase inhibitor.
Furthermore, we show that this effect of myosin II inhibition is unli-
kely to operate via upstream effects on calcineurin signalling, or by
involvement in bulk endocytosis.
In what capacity might myosin II activity be necessary for activ-
ity-dependent structural changes at the AIS? Our current data cer-
tainly cannot rule out the possibility that myosin II plays an
indirect or permissive role in AIS plasticity by acting elsewhere in
dentate granule cells, or in the hippocampal network. However,
they are also consistent with a scenario in which it is directly
involved in the cytoskeletal arrangements that produce AIS short-
ening and relocation. This would certainly be in keeping with
myosin II’s well-characterised roles in stimulus-induced structural
changes and activity-dependent plasticity elsewhere in the neuron.
In developing distal axons, myosin II has well-characterised roles
in growth cone motility (Vallee et al., 2009) and sema3A-induced
axon retraction (Gallo, 2006; Arnold & Gallo, 2014). In dendrites,
it is necessary for spine maturation (Ryu et al., 2006; Rubio et al.,
2011; Koskinen et al., 2014), while distinct myosin II isoforms are
also critical for the normal maturation of speciﬁc dendritic com-
partments and pathway-speciﬁc synaptic function (Ozkan et al.,
Fig 3. Myosin II inhibition does not block activity-dependent calcineurin signalling. Example single-plane images (left) of NFAT-GFP-expressing dentate gran-
ule cells after treatment with NaCl or KCl in the presence of DMSO or 50 lM blebbistatin. Dist, nucleus:cytoplasm distribution for each image; scale bar,
10 lm. Plot (right) shows NFAT-GFP nucleus:cytoplasm distribution (see Methods) in each treatment group. Each symbol represents one cell; lines show
mean  SEM. ****, 2-way ANOVA with Tukey’s multiple comparison test, P < 0.0001.
Fig 4. AIS shortening is not dependent upon endocytosis. Example maximum intensity projection images (left) of dentate granule cells labelled for ankyrin-G
(AnkG) and prox1 (Px1) following 3 hr NaCl or KCl treatment in the presence of DMSO or 80 lM dynasore. Yellow lines, axon start; white arrowheads, AIS
start and end positions; AISL, AIS length; scale bar, 10 lm. Plot (right) shows cumulative fraction and (inset) mean  SEM of AIS length. Two-way ANOVA
with Tukey’s multiple comparison test; ***, P < 0.0001.
© 2017 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
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2015). Myosin II activity is also crucial for the stability of long-
term potentiation (Rex et al., 2010).
Recent evidence that myosin II can interact directly with the mas-
ter AIS scaffolding molecule ankyrin-G (Dash et al., 2016) suggests
that it could be an integral part of the AIS’s sub-membraneous
structure, and may be in an ideal position to affect molecular change
in response to alterations in electrical activity. Our immunocyto-
chemical data (Fig. 2) also show that, while it is not speciﬁcally
localised to or concentrated at the structure, myosin II appears to be
present at the AIS. It therefore has at least the potential to act
locally during activity-dependent plasticity. The possibility that myo-
sin II might be speciﬁcally involved in AIS plasticity, rather than in
the maintenance of AIS structure per se, is also underlined by the
complete lack of effect on AIS length or position when its activity
is blocked under baseline activity conditions, even for 48 h (Fig. 1).
This suggests that myosin II could be a specialised AIS component,
called into action only when structural alterations are required in
response to chronic alterations in ongoing activity.
But how exactly might myosin II contribute to structural changes at
the AIS? If it is directly and locally involved in AIS plasticity, this
involvement is most likely to depend on interactions with the spe-
cialised actin cytoskeleton in the proximal axon. This not only organ-
ises – like the rest of the axon – into stable, regularly spaced
transverse rings linked by longitudinally arranged spectrin molecules
but also contains distinct ‘patches’, where actin is densely organised
into non-parallel meshworks, as well as deeper actin ‘hotspots’, which
may generate a more dynamic actin cytoskeletal network (Watanabe
et al., 2012; Xu et al., 2013; D’Este et al., 2015; Ganguly et al.,
2015; Leterrier et al., 2015). Myosin II interactions with any of these
actin cytoskeletal features could potentially result in substantial struc-
tural AIS alterations. Interestingly, the mechanism of action of myosin
II has been shown to depend on the organisation of the actin ﬁlaments
with which it interacts – while parallel actin ﬁlaments are more likely
to be stabilised by myosin II, the same motor protein can contract and
disassemble antiparallel ﬁlaments (Reymann et al., 2012). A canoni-
cal myosin II contractile motor function might therefore be involved
in the mechanics of AIS structural plasticity, perhaps via interactions
with parallel axonal actin ring structures. Alternatively, or in addition,
myosin II’s role in active actin depolymerisation may be a crucial step
in breaking down the tight relationship between the ankyrin-G/bIV-
spectrin scaffold and the actin cytoskeleton (Xu et al., 2013; Leterrier
et al., 2015), especially at nonparallel actin patches or hotspots. This
may then allow removal of AIS components in rapid activity-depen-
dent shortening, to be followed by subsequent AIS relocation. No
doubt super-resolution microscopy investigating the interactions
between myosin II and actin, both at rest and during conditions of ele-
vated neuronal activity, will soon shed more light on the precise
molecular mechanisms of AIS plasticity.
Upstream factors known to mediate activity-dependent structural
change at the AIS include L-type CaV1 calcium channels and the cal-
cium-activated phosphatase calcineurin (Evans et al., 2013, 2015;
Chand et al., 2015). How might these signalling pathways be linked
to myosin II activity? Discounting any effects of myosin II upstream
of calcineurin signalling (Fig. 3), or any role for calcineurin- and
myosin II-dependent bulk endocytosis in AIS plasticity (Fig. 4), prime
suspects include direct calcineurin activation of the coﬁlin phos-
phatase slingshot (Wen et al., 2007; Yuen & Yan, 2009), or indirect
modulation of actin-myosin II interactions via calcineurin-dependent
regulation of protein synthesis (Graef et al., 1999; Flavell et al.,
2006; Qiu & Ghosh, 2008; Li et al., 2009), and these remain promis-
ing targets for future investigation. Finally, uncovering a speciﬁc
molecular player in the process of AIS plasticity may also shed light
on neuronal strategies for integrating multiple mechanisms of activity-
dependent change (Turrigiano, 2011). While calcineurin signalling is
known to be involved in multiple, sometimes opposing plastic pro-
cesses (Evans et al., 2015), blocking AIS changes alone via speciﬁc
inhibition of myosin II might allow the functional effects of structural
AIS plasticity to be studied in effective isolation.
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